Home - BJH

Outcomes in adolescent and young adult patients compared to younger patients treated for high-risk B-lymphoblastic leukaemia
First-line triple combination chemotherapy for patients with AML
RMAT designation to obecabatagene autoleucel by FDA for patients with acute lymphoblastic leukaemia

Study finds new clinical features associated with rare subcutaneous panniculitis-like T-cell l...

Pharma News

FDA grants priority review to novel haemophilia A treatment efanesoctocog alfa

relevant literature for your daily practice selected by: Kirsten Saevels

Clinical practice

Combination maintenance therapy improves survival in TP53-deficient AML post-HSCT

Health Innovation

Wearable device for tracking temperature of paediatric blood cancer patients at home

Clinical trials

Run To Kick benefits Belgian children with cancer more than ever before

Prevention

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic ...

Cancer-associated thrombosis awareness survey (ECPC)

Show me

Also interesting

General

Sickle Cell Disease; more than sickled red blood cells

Science

Cardiovascular mortality in cancer survivors more likely than in the general population

Clinical trials

Gilteritinib maintenance improves overall survival in relapsed /refractory FLT3+ AML

Medical Research

Leukaemia remission for a decade after CAR-T cell therapy

Table of Contents:

Outcomes in adolescent and young adult patients compared to younger patients treated for high-risk B-lymphoblastic leukaemia

First-line triple combination chemotherapy for patients with AML

RMAT designation to obecabatagene autoleucel by FDA for patients with acute lymphoblastic leukaemia

Recommended

Science

Study finds new clinical features associated with rare subcutaneous panniculitis-like T-cell l...

Pharma News

FDA grants priority review to novel haemophilia A treatment efanesoctocog alfa

Editor's pick

relevant literature for your daily practice selected by: Kirsten Saevels

Clinical practice

Combination maintenance therapy improves survival in TP53-deficient AML post-HSCT

Health Innovation

Wearable device for tracking temperature of paediatric blood cancer patients at home

Clinical trials

Run To Kick benefits Belgian children with cancer more than ever before

Prevention

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic ...

Cancer-associated thrombosis awareness survey (ECPC)

Also interesting

General

Sickle Cell Disease; more than sickled red blood cells

Science

Cardiovascular mortality in cancer survivors more likely than in the general population

Clinical trials

Gilteritinib maintenance improves overall survival in relapsed /refractory FLT3+ AML

Medical Research

Leukaemia remission for a decade after CAR-T cell therapy